Further colour has emerged on India’s approval of the Praxair-Linde merger, with a statement from the country’s Competition Commission (CCI) detailing the remedies required for clearance.
News surfaced of the CCI’s conditional approval last week, after the organisation had tweeted, “CCI_India approves combination of Linde and Praxair, subject to compliance of certain modifications.”
India approves Praxair-Linde deal
The competition regulator has now issued an official statement, which confirms that, “Based on its investigation, the Commission was of the opinion that the proposed combination is likely to have an appreciable adverse effect on competition in some markets in India but the same could be addressed by way of modifications to the proposed combination.”
... to continue reading you must be subscribed
